
EMA greenlights new medicines
With the three innovative medicines and four generics the number of recommended medicines raised to 47 in 2019. The Committee saw a positive...

Test detects breast cancer in earliest stage
The new research results were presented at the 2019 NCRI Cancer Conference today by Daniyah Alfattani from National Cancer Research Institute (NCRI)...

PFF Group NV acquires stake in Autolus Therapeutics
With the investment into London-headquartered Autolus Therapeutics, PPF Group N.V. significantly increased its commitment to the healthcare sector....

AMR: ENABLE selects Mutabilis candidate
Efficacy of beta-lactam antibiotics, which represent 65% of the antibiotics sold throughout the world, is increasingly challenged in Gram-negative...

EU with poor success in fighting superbugs
Although some progress has been made through EU action, there is little evidence so far to suggest that the health burden of antimicrobial resistance...

bit bio restarts with new management
Cambridge-based cell reprogramming specialist Elpis Biomed will be re-started under the new name bit bio with a new management and an extended...

Vaximm goes East for cancer vaccine deal
T-cell immunotherapy expert Vaximm plans to use Artificial Intelligence (AI) to develop personalised cancer vaccines. The biotech is collaboration...